408 related articles for article (PubMed ID: 30187581)
1. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
[TBL] [Abstract][Full Text] [Related]
2. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
[TBL] [Abstract][Full Text] [Related]
4. Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys.
Lin X; Goyal R; Yang XJ
Hum Pathol; 2020 Mar; 97():1-7. PubMed ID: 31857138
[TBL] [Abstract][Full Text] [Related]
5. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With Clinical Follow-up.
Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
[TBL] [Abstract][Full Text] [Related]
8. Acquired cystic disease subtype renal cell carcinoma (ACD-RCC): prevalence and imaging features at a single institution.
Carnahan MB; Kunzelman J; Kawashima A; Patel BN; Menias CO; Fananapazir G
Abdom Radiol (NY); 2022 Aug; 47(8):2858-2866. PubMed ID: 35674787
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary Malignancies in Transplant or Dialysis Patients: The Frequency of Two Newly Described 2016 World Health Organization Histopathologic Types.
Billis A; Freitas LLL; Costa LBE; Barreto IS; Asato MA; Araujo KS; Losada DM; Herculiani AP; Tabosa GVBS; Zaidan BC; Oliveira GLP; Bastos LQA; Rocha RM
Transplant Proc; 2017 Oct; 49(8):1783-1785. PubMed ID: 28923625
[TBL] [Abstract][Full Text] [Related]
13. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia.
Hosseini M; Antic T; Paner GP; Chang A
Hum Pathol; 2014 Jul; 45(7):1406-13. PubMed ID: 24775605
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis.
Denton MD; Magee CC; Ovuworie C; Mauiyyedi S; Pascual M; Colvin RB; Cosimi AB; Tolkoff-Rubin N
Kidney Int; 2002 Jun; 61(6):2201-9. PubMed ID: 12028461
[TBL] [Abstract][Full Text] [Related]
15. [A Case of ACD-Associated RCC with Lymph Node Metastasis and Contralateral Renal Carcinoma after Nephrectomy].
Makino Y; Tsuchihashi K; Shimizu Y; Kanamaru S; Hashimoto K; Ito N
Hinyokika Kiyo; 2016 Jul; 62(7):349-53. PubMed ID: 27569352
[TBL] [Abstract][Full Text] [Related]
16. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis.
Hughson MD; Buchwald D; Fox M
Arch Pathol Lab Med; 1986 Jul; 110(7):592-601. PubMed ID: 3521533
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic profiling indicates the proximal tubule origin of renal cancers in end-stage renal disease.
Ishihara H; Yamashita S; Liu YY; Hattori N; El-Omar O; Ikeda T; Fukuda H; Yoshida K; Takagi T; Taneda S; Kondo T; Nagashima Y; Tanabe K; Ushijima T
Cancer Sci; 2020 Nov; 111(11):4276-4287. PubMed ID: 32860304
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation.
Peces R; Martínez-Ara J; Miguel JL; Arrieta J; Costero O; Górriz JL; Picazo ML; Fresno M
Nephrol Dial Transplant; 2004 Nov; 19(11):2789-96. PubMed ID: 15316098
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
[TBL] [Abstract][Full Text] [Related]
20. Acquired cystic disease of the kidneys and renal cell carcinoma in chronic renal insufficiency without dialysis treatment.
Chung-Park M; Parveen T; Lam M
Nephron; 1989; 53(2):157-61. PubMed ID: 2812171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
